Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer
about
A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancerSecreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancerSecreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signalingWnt/β-catenin signalling in prostate cancerThe role of Wnt5a in prostate gland development.Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostateModeling the prostate stem cell niche: an evaluation of stem cell survival and expansion in vitro.Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinomaTranscriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and diseaseGlobal gene expression analysis of reactive stroma in prostate cancer.Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genesMinireview: the molecular and genomic basis for prostate cancer health disparitiesMolecular signaling pathways that regulate prostate gland development.Gene targeting to the stroma of the prostate and bone.Reduction of pro-tumorigenic activity of human prostate cancer-associated fibroblasts using Dlk1 or SCUBE1.The tumor microenvironment in colorectal carcinogenesis.Expression changes in the stroma of prostate cancer predict subsequent relapseMyofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effectIdentification of secreted glycoproteins of human prostate and bladder stromal cells by comparative quantitative proteomics.Persistent inflammation leads to proliferative neoplasia and loss of smooth muscle cells in a prostate tumor modelDiagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer.Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasisProstate stromal and urogenital sinus mesenchymal cell lines for investigations of stromal-epithelial interactions.Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostateHuman Stromal Cells in the Peripheral Zone of the Prostate Promote Tumorigenesis of Prostatic Cancer Stem Cells through Up-regulation of C-Kit Expression.Discovering Pair-wise Synergies in Microarray DataStromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.Wnt inhibitory factor 1 (Wif1) is regulated by androgens and enhances androgen-dependent prostate development.The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapiesMiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cellsTear levels of SFRP1 are significantly reduced in keratoconus patientsRecent advances in prostate development and links to prostatic diseasesPhysiopathological aspects of the Wnt/β-catenin signaling pathway in the male reproductive systemAndrogen regulation of epithelial-mesenchymal transition in prostate tumorigenesisEpithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases.Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate.EWS/ETS regulates the expression of the Dickkopf family in Ewing family tumor cells.Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues
P2860
Q21136388-E245C76A-467B-4517-B0E2-4ED180C555C7Q24319970-384D51DC-2206-4F75-BEE0-14E1FAB80B09Q28115695-BD62942F-3833-4C36-9E84-C6186D20161CQ28269116-019E06CD-572D-4EEF-A0BE-9280CC22D272Q28565427-AF68727F-8A01-41C6-957E-A44A75D71A06Q28584870-C10820CC-4B0F-47C3-8E98-14B37610FACAQ30503574-7DB77E0B-9B13-4868-A1D1-360A345D870DQ33290638-D00F568C-0B80-4781-8E39-72172B5C739DQ33301957-210C22C0-6E02-475C-BE0E-5212BB0C1167Q33464811-D2E0F943-0C78-44B1-820A-6CE808867A75Q33500845-4CAB0434-1DBF-47E1-9ECA-A792765AA7CBQ33633160-7B10F980-CD68-4DDC-A457-6BD8B31F81DCQ33666315-F7465AD2-3D23-41A7-9365-844322D291B5Q33699188-BA61EC9E-C5AF-4BA9-B1DA-C1656A2B4B1CQ34310539-49BEEAAC-EE9D-4B34-8FC9-EF17DAC62052Q34343645-0CFB68E3-F6F8-4C78-8485-BE8E143AC954Q34368873-45730FCE-EB5B-4341-99D8-72FAAA4223F6Q34535147-2C3512D9-2153-4FC7-BF2B-4E93E90F91F9Q34802793-BEC2AD55-7543-41A1-AD4B-BCA7116775B6Q35166311-04BF284F-7E52-4D44-8281-CC449C148BD7Q35568239-823711AF-36CD-4436-A015-2C197FA62554Q35679829-A1D140AE-F812-4404-8EF3-CF145395DCFCQ35800799-B2A51D34-AA54-45EC-B55F-2A38F4747555Q35838295-3700276C-9169-4896-A636-C28FE499E84AQ35856865-4C6CF91C-A585-4362-B85A-16B8FE0744BEQ36089234-99C81FDE-569B-4CA8-9190-6FD7E6A7AD7FQ36140754-18742DF9-D417-4515-A380-8EB7E3A3677EQ36439567-ACC6540D-64F0-4BF4-9568-4EB04C6A28F1Q36515479-7853F097-599C-4DC1-A8CB-B603192BB752Q36557159-95453621-5862-47B4-890B-1FC1072A7515Q36627473-07F6E664-0514-4FEF-B8E2-142748F35FB3Q36634661-D15F6F95-4534-479A-8B19-C0546270B58BQ36642727-DEF0D986-195D-4E7B-BCF9-CEB7AF057C18Q36815379-08BE4463-04E8-451F-94BB-ED180D1A817DQ36827512-EAE5C0DD-0C43-4E0F-9662-9256F8448D61Q36857803-48A4020F-3F78-453C-A875-67E17FF60F8EQ37074256-CB8C266D-7059-4AFD-B003-681346B90B04Q37102448-9F98872F-23A2-4BF6-87F1-79627E221A86Q37178620-1B315472-4A8E-4E90-9F02-ABCA26E8B872Q37318729-9E5DE349-AFD9-4FC1-8C0E-4D0D8DE02476
P2860
Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@ast
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@en
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@en-gb
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@nl
type
label
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@ast
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@en
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@en-gb
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@nl
prefLabel
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@ast
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@en
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@en-gb
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@nl
P2093
P921
P3181
P1433
P1476
Identification of SFRP1 as a c ...... l signaling in prostate cancer
@en
P2093
Brian Elenbaas
Gerald R Cunha
Jeffrey S Rubin
Margaret S Joesting
Omar E Franco
Paul C Marker
Stephen E Fawell
Steve Perrin
P304
10423-10430
P3181
P356
10.1158/0008-5472.CAN-05-0824
P407
P577
2005-11-01T00:00:00Z